Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Another subsidiary that I was unaware of
View:
Post by LivefromWest5 on Jan 13, 2021 4:45pm

Another subsidiary that I was unaware of

This may not amount to anything, but I had never seen anything about this in my previous digging into the company before becoming Medivolve. Thought I would share.

40% stake in Amino Therapeutics who are attempting to contribute to the vaccination effort.

https://themarketherald.ca/questcap-sign-loi-to-acquire-40pc-interest-in-amino-therapeutics-2020-04-03/

https://www.aminothera.com
Comment by NobleFr on Jan 13, 2021 9:23pm
Yes there is actually a lot going on under the hood for this company. If you dig deeper into Amino Therapeutics and Xenomics, you can see they have developed a revolutionary technology for bioengineering. A lot of potential there. If they hit a covid-19 treatment or other breakthrough this could be big. But Doug Sommerville said in a webinar in December that there was nothing material to ...more  
Comment by NobleFr on Jan 13, 2021 9:34pm
If you want to learn more about the parent company, go on the CEO David Preiner's Linkedin page, there's an investor presentation for Xenomics.  You have to be logged in for the link to work: https://www.linkedin.com/in/davidpreiner/detail/treasury/position:1596600808/?entityUrn=urn%3Ali%3Afsd_profileTreasuryMedia%3A(ACoAABzbsioBg6HOWcN48VU-uiC4EOvx4lZwJYs%2C1584339432613)& ...more  
Comment by LivefromWest5 on Jan 14, 2021 10:26am
Thanks for the reply NobleFr, very interesting!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities